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Abstract
Many chemotherapeutic drugs have had success in treating a variety of
cancers, but some can be harmful and cause adverse side affects such as hair loss
and nausea. Cisplatin is a well-known chemotherapy drug that has been used to
treat a countless number of different types of cancers including non-small cell lung
cancers (NSCLC). Because of its nonspecificity and secondary effects, investigation
into alternative non-small cell lung cancer targeting drugs is necessary. The recently
synthesized bis-cation imidazolium salt system has displayed antiproliferative
activity, but its mechanism of action remains undetermined. The system explores
the use of two napthalenes, two imidazole salts, and linking carbon chains varying
from 1-12 carbons in length. Here, the system was tested for possible DNA
intercalation using fluorescent intercalator displacement (FID) and viscosity
experimentation. Results from FID exhibit negligible displacement activity of ethidium
bromide from the 4 selected compounds. In contrast, viscosity results demonstrate 3 of 4
compounds showing greater DNA interaction compared to the acridine orange control.
These opposing conclusions ultimately determine DNA interaction is present, but not
strong enough to effectively displace a known intercalator. Overall, results do not
concretely reveal a mechanism of DNA interaction.

Introduction
Of the 224,390 predicted new cases of lung cancer in 2016 over 83% will be nonsmall cell lung cancers (NSCLC).1 Treatments for lung cancer vary from surgery,
radiation, to chemotherapy and the method and drug chosen for treatment are specifically
tailored to each patient. Cisplatin proves to be very effective and widely used as a
chemotherapy drug, but it is known to cause harmful side effects to non-cancer cells.2
Improving upon current cancer-targeting drugs leaves the possibility for the development
of more effective and safer compounds to use for the treatment of NSCLC.
Distinguished professor Dr. Wiley Youngs’ research group works with
imidazolium salts as a means to better treat NSCLC. By varying the ligand additions to
the various positions of the imidazole ring, the Youngs lab has developed numerous anticancer compounds, of which methyl naphthalene on the nitrogen atoms of the imidazole
give the best activity. While these compounds exhibit antiproliferative activity, success
has been limited due to poor solubility.3 Synthesized imidazole compounds thus far must
first be dissolved into either dimethyl sulfoxide (DMSO) or cyclodextrin before testing.
Echinomycin and ethidium bromide are known compounds with planar aromatic
structure that allow for DNA intercalation. Echinomycin specifically exhibits double
intercalation behavior.4 This double intercalation is of interest for the bis-imidazolium
salt compounds as a possible mechanism of drug targeting. Recently, the Youngs lab has
taken interest in synthesizing a bis-cation system, which consists of two napthalenes, two
imidazole salts, and a linking chain between them that varies in length from 1-12 carbons.
This bis-cation system produces more polar compounds, increasing the chances of
aqueous solubility.

Figure 1. Displays the general structure of the bis-cation system, where n is the varying
number of carbon atoms connecting the two chains and the R groups in the 4, 5 positions
of the imidazole salts are defined as hydrogen.

Because the bis-cations have shown increased polarity and solubility, the purpose
of this project is to test the potential intercalation of the system by means of viscosity and
fluorescent intercalator displacement (FID) to determine any intercalation with DNA.
Analyzing viscosity, it is hoped that these compounds increase the viscosity of the DNA,
meaning the backbone has been slightly unwound to ease the strain caused by the
intercalating compound.5 FID experiments using ethidium bromide will aid in
demonstrating the possible intercalation properties of the bis-cations. It is hoped that a
decrease in fluorescence will be seen, implying the displacement of the ethidium bromide
by the compound.6 If this analysis proves useful in better understanding the mechanism
of the bis-cation compounds, new compounds can be synthesized specific to the binding
mechanism.
Methods
The bis-cation system was tested for intercalating behavior by both viscosity and
fluorescent intercalator displacement (FID). The system contained linker compounds
ranging from 1-12 carbons in length. For time convenience, 4 of the 12 compounds were
chosen for experimentation: methyl, propyl, pentyl, and heptyl. All compounds were first

solubilized in DMSO (10%) and diluted to 1mL with Invitrogen™ Ultra Pure Distilled
Water (DNAse, RNAse free).
Invitrogen™ calf thymus DNA 10 mg/mL; Thermo Fisher Scientific stock
solutions were separately prepared for each testing method. For a concentration between
115 μM and 135 μM for FID, 30 mL of Tris/NaCl (5mM/50mM) buffer and 110 μL of
calf thymus DNA were added to a falcon tube and vortexed. For a concentration between
225 μM and 250 μM for viscosity, 70mL of Tris/NaCl (5mM/50mM) buffer and 560 μL
of calf thymus DNA were added to a falcon tube and vortexed. An Agilent Varian Cary®
100 Bio UV-Visible Spectrophotometer was used to determine the concentrations of the
prepared DNA solutions. The instrument was warmed up for 20-30 minutes. The
software was opened and the instrument was zeroed. Tris/NaCl (5mM/50mM) buffer was
added to the blank cuvette and placed in the back of instrument as the reference. DNA
solution was added to the sample cuvette and placed in the front of the instrument. After
absorbance values were collected between 200 nm and 800 nm, x and y peaks were
labeled on the graph and the DNA absorbance value was recorded at 258 nm. The BeerLambert equation was utilized to calculate the concentration of the DNA solution using
the recorded absorbance and extinction coefficient (6600 M-1 cm-1).7
Fluorescent intercalator displacement was conducted based on the procedure
previously described by Boger et al. (2001). A HORIBA Jobin Yvon Fluoromax-4
Spectrofluorometer was used to conduct FID testing. The Fluoromax-4 was warmed up
for at least 30 minutes. With no cuvette in the instrument, a lamp excitation spectrum was
collected to determine the initial intensity. Nanopure water (3 mL) was added to the
cuvette and an emission spectrum was collected. Both lamp and water spectra were

collected using default parameters. Nanopure water was discarded and a 120 μM DNA
solution (2.997 mL) and 3 μL of ethidium bromide were added to the cuvette. The
excitation wavelength was set at 510 nm and the emission wavelength range was set
between 465 nm and 750 nm. An initial emission spectrum was collected before any
compound was titrated. Compound was then titrated in from 0-30 μL by 2 μL additions,
30-100 μL by 10 μL additions, and 100-600 μL by 100 μL additions, and all emission
spectra were recorded. A pipette was used to thoroughly mix each addition and the
solution was given 2 minutes between each reading to equilibrate. Intensity values were
normalized against the blank to account for the lamp intensity decreasing with each use.
Normalized intensities were graphed against concentration of the solution.
Viscosity testing was based on the procedure carried out by Xia-Bing Fu et al.
(2014). A viscometer and thermometer were placed into a water bath. The water bath sat
atop a VWR heating/stirring plate and was kept between 29°C and 30°C throughout
testing. Tris/NaCl buffer (8 mL) was placed into the large bulb of the viscometer. A bulb
was used to entirely coat the large and small arms of the viscometer. Timing began as the
solution crossed the line above the small bulb and ended where the solution crossed the
line below the small bulb. Flow times were recorded in triplicate. The buffer was
discarded and a 250 μM DNA solution (8mL) was added to the viscometer and flow
times were recorded in triplicate. To the DNA, 7 separate 8 μL additions of the select bisimidazoium cation were titrated into the solution. The bulb was used to draw solution
into the small arm to collect the addition, the initial flow through was not recorded, and
air was bubbled through the viscometer from the small arm to ensure complete mixing
before any readings of the additions were taken. All 8 μL additions flow times were

recorded in triplicate. Triplicate trials of the buffer, DNA, and DNA and additions were
averaged and normalized against the buffer.
It should be noted that extreme sensitivity associated with this technique renders
viscosity data highly variable and sometimes inaccurate. Multiple factors influence the
flow time: recording entry and exit into the small bulb, temperature, and thorough mixing
of additions into solution.
Results and Discussion
Fluorescent intercalator displacement provides insight into the affinity for DNA
of the bis-cation compounds. This technique measures changes in fluorescence intensity
of a solution. When ethidium bromide intercalates between DNA base pairs, fluorescence
significantly increases. Utilizing this fluorescent compound, the degree to which the
titrated compound displaces ethidium bromide and binds to DNA can be determined. As
ethidium bromide is displaced by the compound, fluorescence should decrease.8 FID
experimentation was conducted on netropsin for means of comparison to the compounds.
Netropsin is a known groove binder that has the ability to displace ethidium bromide.8 To
ensure neither the DMSO nor water resulted in a decrease in fluorescence intensity, a
10% DMSO in water solution was used as a vehicle control.
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Figure 2. Figure 2 displays the graph of normalized intensities vs. the concentration of
compound of the vehicle control, netropsin, and the four compounds.
All compounds show some degree of ethidium bromide displacement; however,
the observed displacement is not significant as compared to the netropsin shown by the
red line. No bis-cation compound comes close to rate of decreasing fluorescence intensity
in comparison to netropsin. This pattern continues into the 30-100 μL and 100-600 μL
additions. The orange line from the graph represents the heptyl compound and proves
most effective in ethidium bromide displacement of all four compounds. Overall, the
compounds did not display a stronger affinity for DNA due to their lack of displacement
of the ethidium bromide.
Viscosity testing was also used to determine any intercalating behavior of
compounds. DNA intercalation causes an increase in flow time. Compound intercalation
causes unwinding of the DNA backbone in order to reduce strain. This base pair
separation lengthens the DNA and increases viscosity.9 Acridine orange and a 10%
DMSO in water solution were used as a known comparison and vehicle control
respectively.

(N/No)1/3

Viscosity
1.4
1.35
1.3
1.25
1.2
1.15
1.1
1.05
1
0.95

Vehicle Control
Acridine Orange
Methyl
Propyl
Pentyl
Heptyl
0

0.1
0.2
[compound]/[250μM]

0.3

Figure 3. Figure 3 displays the graph of normalized viscosities vs. the concentration of
compound by titration divided by the concentration of the DNA stock solution of the
vehicle control, acridine orange, and the four compounds.

Contrary to FID, three of the four compounds displayed slower flow rates
compared to the acridine orange control. These increases in viscosity suggest that the
propyl, pentyl, and heptyl compounds exhibit DNA interactions to a higher degree than
the control.
Interestingly, the methyl compound experienced solubility issues. Using twice the
mass compared to FID, the 10% DMSO in water solution proved insufficient to
completely solubilize the compound. Poor solubility of the compound may decrease its
actual intercalating potential. No other compounds experienced these issues.
While FID testing concluded insignificant displacement of ethidium bromide,
viscosity testing showed three of the four compounds possessing increased viscosities
compared to the control. This contradicting data indicates interaction between the
compound and DNA may be present, but is not strong enough to effectively displace a
known intercalator such as ethidium bromide. Results from this experiment cannot

provide a concrete mechanism of DNA interaction of the compounds. Future research
will likely investigate other mechanisms of action of the bis-cation species.
Conclusion
The recently synthesized bis-cation system exhibits more polar imidazolium salts,
causing increased solubility. The purpose of this project was to test for possible
intercalation of DNA. Experimentation was conducted by both FID and viscosity
measures. The compounds displayed insignificant displacement of ethidium bromide
compared to the Netropsin control. The heptyl compound exhibited the greatest
intercalation of the compounds, but compared to the control its activity was negligible.
Viscosity testing concluded the propyl, pentyl, and heptyl compounds showed increased
viscosity times compared to the acridine orange control. Overall, the compounds
exhibited some interaction with the DNA, but this interaction was not strong enough to
displace a known intercalator.
Solubility remains the issue at large. The larger linker compounds exhibit
increased degrees of intercalation, but their size causes solubility issues in the 10%
DMSO in water solutions. A possible solution to avoid sacrificing intercalation for
solubility is to test other solvents apart from DMSO and water for solubilizing
compounds. Cyclodextrin may prove a viable option for compound solubility issues
because of its ability to bind the compound into its lipophilic pocket.
From this experiment, it was determined that the bis-cation system causes a small
degree of DNA intercalation, which proves to be too insignificant for a valid mechanism
of action. In future research, it is likely the lab will test for alternative mechanisms of
action rather than continuing to experiment with DNA interactions.
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Safety Appendix
Common precautions were taken the entire duration of this research. Gloves,
goggles, proper shoes, working in the hoods, and an optional lab coat were used at all
times during experimentation. Undergraduate students were aware of fire extinguisher
and eye wash station locations.
Special attention was paid when handling and disposing of netropsin, ethidium
bromide, acridine orange, DMSO, and calf thymus DNA. In this case, netropsin was
mixed with ethidium bromide from FID experimentation. The combination of netropsin,
ethidium bromide, and calf thymus DNA were discarded in a liquids waste container
specifically for ethidium bromide titrated with imidazolium salt compounds. All tips,
Kimwipes, and gloves that came into contact with ethidium bromide were disposed of in
a designated solids waste container. Undergraduate students never pipetted from the
ethidium bromide stock solution. From viscosity testing, acridine orange, imidazolium
salt compounds, and calf thymus DNA solutions were discarded in the proper liquids
waste container that did not contain ethidium bromide. Tips that came into contact with
acridine orange, imidazolium salt compounds, and calf thymus DNA were discarded in a
specific solids waste container.
The full properties of the imidazolium salts were unknown. Preventative measures
including limited exposure, gloves, and goggles were carried out in times of working
with those compounds. DMSO (10%) in water and compound solutions were discarded in
a specific liquids waste container. Because it is generally regarded as safe (GRAS),
cyclodextrin may prove a viable option for safely solubilizing compounds compared to
DMSO.

